Fate Therapeutics Inc (FATE)
3.68
+0.23
(+6.67%)
USD |
NASDAQ |
May 31, 16:00
3.70
+0.02
(+0.54%)
After-Hours: 20:00
Fate Therapeutics Revenue (Annual): 63.53M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.53M |
| December 31, 2022 | 96.30M |
| December 31, 2021 | 55.85M |
| December 31, 2020 | 31.43M |
| December 31, 2019 | 10.68M |
| December 31, 2018 | 4.74M |
| December 31, 2017 | 4.106M |
| Date | Value |
|---|---|
| December 31, 2016 | 4.402M |
| December 31, 2015 | 2.431M |
| December 31, 2014 | |
| December 31, 2013 | 0.971M |
| December 31, 2012 | 2.67M |
| December 31, 2011 | 1.17M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
10.68M
Minimum
2019
96.30M
Maximum
2022
51.56M
Average
55.85M
Median
2021
Revenue (Annual) Benchmarks
| Amicus Therapeutics Inc | 399.36M |
| Ocular Therapeutix Inc | 58.44M |
| Alpine Immune Sciences Inc (DELISTED) | 58.88M |
| AnaptysBio Inc | 17.16M |
| Stoke Therapeutics Inc | 8.78M |